Dr. Eli Kolp is the trail breaking pioneer who first described the use of ketamine for therapeutic transpersonal applications. Ketamine is the only psychedelic that can be legally prescribed by physicians at this time. His clinical research opened the door to a new generation of ketamine practitioners.

He was born and educated in the former Soviet Union. His parents, both physicians, practiced medicine throughout Central Asia, and the family lived in several different republics before settling in Moscow in 1970. Dr. Kolp completed medical school in 1973, a surgical Internship in 1974 and residency training in psychiatry in 1978. He practiced psychiatry In Moscow until 1981, when he immigrated to the United States.

He completed a second residency In psychiatry in 1987 at the University of Texas Medical School in Houston. While there, he accepted the position of Assistant Professor in the Department of Psychiatry.

In 1988, Dr. Kolp moved to Tampa to continue his education at the University of South Florida College of Medicine, where he completed a fellowship in Geriatric Psychiatry in 1989. During the same year, Dr. Kolp became a Diplomate of the American Board of Psychiatry and Neurology. Since that time, Dr. Kolp has maintained his interests In both academic and clinical psychiatry. He joined the faculty of the Department of Psychiatry as Clinical Assistant Professor at the USF College of Medicine and has served in the position of medical director in several psychiatric hospitals in the Tampa Bay area, directing both residential and outpatient treatment programs.

In 1994, Dr. Kolp began researching ketamine psychedelic psychotherapy while on staff at the James A. Haley Veterans Hospital in Tampa. He continued his research until 1999, when he separated from the VA Hospital. Dr. Kolp has returned to private practice offering ketamine assisted psychedelic psychotherapy. Dr. Kolp has continued his scientific research with ketamine psychedelic psychotherapy and has published the following articles about the results of his studies. Most of these studies can be found on the web and are worthy of your attention.

• Krupltsky E. & Kolp E., 2007. Ketamlne psychedelic psychotherapy. In M. Winkelman & T. Roberts (Eds.), Psychedelic Medicine: Addictions Medicine and Transpersonal Healing, Volume 2, Chapter 5, pp. 67-85. Portsmouth, NH: Praeger.

• Kolp E, Young S, Friedman H, Krupitsky E, Jansen K, & O'Connor L, 2007. Ketamine Enhanced Psychotherapy: Preliminary clinical observations on its effectiveness in treating death anxiety. International Journal of Transpersonal Studies, 26, pp. 1 - 17.

• Kolp E, Krupitsky E, Friedman H, Young S, 2009. Entheogen-enhanced transpersonal psychotherapy of addictions: Focus on clinical applications of ketamine for treating alcoholism. In: A. Browne-MIiier [Ed.]. The Praeger Interhatlonal Collection on Addictions, Vol. 3, pp. 403-417. Westport, CT: Praeger.

• Kolp E, Friedman H, Krupitsky E, Jansen K, Sylvester M, Young S, Kolp A, 2014. Ketamine psychedelic psychotherapy: Focus on its pharmacology, phenomenology and clinical applications. International Journal of Transpersonal Studies, 3, pp. 112-168